Type to search

Entos and BioMarin Enter into Agreement for Product Candidates Incorporating Entos' Fusogenix Drug Delivery Platform | Pharmtech Focus
Entos Raises $53 Million Series A Round Led by Coatue and Catalio | Pharmtech Focus